Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M, Hideshima T, Chauhan D, Joseph M, Libermann TA, García-Echeverría C, Pearson MA, Hofmann F, Anderson KC, Kung AL.

Cancer Cell. 2004 Mar;5(3):221-30.

2.

Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.

Mitsiades CS, Mitsiades N.

Expert Rev Anticancer Ther. 2005 Jun;5(3):487-99. Review.

PMID:
16001956
3.

The therapeutic potential of agents targeting the type I insulin-like growth factor receptor.

Zhang H, Yee D.

Expert Opin Investig Drugs. 2004 Dec;13(12):1569-77. Review.

PMID:
15566314
4.

Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).

Jernberg-Wiklund H, Nilsson K.

Adv Cancer Res. 2007;97:139-65. Review.

PMID:
17419944
5.

Targeted therapy of the insulin-like growth factor-1 receptor in cancer.

Paz K, Hadari YR.

Comb Chem High Throughput Screen. 2008 Jan;11(1):62-9. Review.

PMID:
18220543
6.

Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine.

Hewish M, Chau I, Cunningham D.

Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):54-72. Review.

PMID:
19149688
7.

Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.

van der Veeken J, Oliveira S, Schiffelers RM, Storm G, van Bergen En Henegouwen PM, Roovers RC.

Curr Cancer Drug Targets. 2009 Sep;9(6):748-60. Review.

PMID:
19754359
8.

Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy.

Adachi Y, Lee CT, Carbone DP.

Novartis Found Symp. 2004;262:177-89; discussion 190-2, 265-8. Review.

PMID:
15562829
9.

[Progress in the studies on small molecule IGF-1R inhibitors].

Xu Y, Wang GS, Sun W, Yang XH, Xu LB.

Yao Xue Xue Bao. 2008 Oct;43(10):979-84. Review. Chinese.

PMID:
19127859
10.

The insulin-like growth factor 1 receptor in cancer: old focus, new future.

Hartog H, Wesseling J, Boezen HM, van der Graaf WT.

Eur J Cancer. 2007 Sep;43(13):1895-904. Epub 2007 Jul 10. Review.

PMID:
17624760
11.

Targeting IGF-1 signaling pathways in gynecologic malignancies.

Bruchim I, Werner H.

Expert Opin Ther Targets. 2013 Mar;17(3):307-20. doi: 10.1517/14728222.2013.749863. Epub 2013 Jan 7. Review.

PMID:
23294364

Supplemental Content

Support Center